Beneficial Impact of Ramipril on Left Ventricular Hypertrophy in Normotensive Nonalbummuric NIDDM Patients Diabetes Care May 1998 21:804-809; doi:10.2337/diacare.21.5.804
Patterns of Expenditures and Use of Services Among Older Adults With Diabetes: Implications for the transition to capitated
managed care Diabetes Care May 1998 21:747-752; doi:10.2337/diacare.21.5.747
Development of Proliferative Diabetic Retinopathy in African-Americans and Whites With Type 1 Diabetes Diabetes Care May 1998 21:792-795; doi:10.2337/diacare.21.5.792
Validation of a Diabetic Wound Classification System: The contribution of depth, infection, and ischemia to risk of amputation
Diabetes Care May 1998 21:855-859; doi:10.2337/diacare.21.5.855
Comparison of Human Regular and Lispro Insulins After Interruption of Continuous Subcutaneous Insulin Infusion and in the
Treatment of Acutely Decompensated IDDM Diabetes Care May 1998 21:817-821; doi:10.2337/diacare.21.5.817
Absence of Association Between Genetic Variation of the β3-Adrenercjic Receptor and Metabolic Pnenotypes in Oji-Cree Diabetes Care May 1998 21:851-854; doi:10.2337/diacare.21.5.851
Beneficial Effect on Average Lipid Levels From Energy Restriction and Fat Loss in Obese Individuals With or Without Type 2
Diabetes Diabetes Care May 1998 21:695-700; doi:10.2337/diacare.21.5.695
The Effect of Magnesium Supplementation in Increasing Doses on the Control of Type 2 Diabetes Diabetes Care May 1998 21:682-686; doi:10.2337/diacare.21.5.682
Lispro Insulin Is Suitable for External Pumps but Not for Implantable Pumps Diabetes Care May 1998 21:867-868; doi:10.2337/diacare.21.5.867
Barrow, Beryl A
Changes in Amylin and Amylin-Like Peptide Concentrations ana (β-Cell Function in Response to Sulfonylurea or Insulin Therapy
in NIDDM Diabetes Care May 1998 21:810-816; doi:10.2337/diacare.21.5.810
Use of the Therapeutic Footwear Benefit Among Diabetic Medicare Beneficiaries in Three States, 1995 Diabetes Care May 1998 21:777-781; doi:10.2337/diacare.21.5.777
Evaluation of the Insertion/Deletion ACE Gene Polymorphism as a Risk Factor for Carotid Artery Intima-Media Thickening and
Hypertension in Young Type 1 Diabetic Patients Diabetes Care May 1998 21:836-840; doi:10.2337/diacare.21.5.836
Validation of a Diabetes-Specific Quality-of-Life Scale for Patients With Type 1 Diabetes Diabetes Care May 1998 21:757-769; doi:10.2337/diacare.21.5.757
Do Postmenopausal Women With NIDDM Have a Reduced Capacity to Deposit and Conserve Lower-Body Fat? Diabetes Care May 1998 21:828-830; doi:10.2337/diacare.21.5.828
International Diabetes Federation Meeting, 1997: Type 2 diabetes: its prevalence, causes, and treatment Diabetes Care May 1998 21:860-865; doi:10.2337/diacare.21.5.860
Validation of a Diabetes-Specific Quality-of-Life Scale for Patients With Type 1 Diabetes Diabetes Care May 1998 21:757-769; doi:10.2337/diacare.21.5.757
Moderate Intake of n-3 Fatty Acids for 2 Months Has No Detrimental Effect on Glucose Metabolism and Could Ameliorate the Lipid
Profile in Type 2 Diabetic Men: Results of a controlled study Diabetes Care May 1998 21:717-724; doi:10.2337/diacare.21.5.717
Effect of Meal Dilution on the Postprandial Glycemic Response: Implications for glycemic testing Diabetes Care May 1998 21:711-716; doi:10.2337/diacare.21.5.711
Use of a Laser Skin Perforator for Determination of Capillary Blood Glucose Yields Reliable Results and High Patient Acceptability
Diabetes Care May 1998 21:871-873; doi:10.2337/diacare.21.5.871
Burke, John
The Effects of Metformin on Glycemic Control and Serum Lipids in Insulin-Treated NIDDM Patients With Suboptimal Metabolic
Control Diabetes Care May 1998 21:701-705; doi:10.2337/diacare.21.5.701
Enhanced Subclinical Coagulation Activation During Diabetic Ketoacidosis Diabetes Care May 1998 21:868-870; doi:10.2337/diacare.21.5.868
C
Campbell, Lesley V
The Determinants of Glycemic Responses to Diet Restriction and Weight Loss in Obesity and NIDDM Diabetes Care May 1998 21:687-694; doi:10.2337/diacare.21.5.687
Beneficial Effect on Average Lipid Levels From Energy Restriction and Fat Loss in Obese Individuals With or Without Type 2
Diabetes Diabetes Care May 1998 21:695-700; doi:10.2337/diacare.21.5.695
The Effect of Magnesium Supplementation in Increasing Doses on the Control of Type 2 Diabetes Diabetes Care May 1998 21:682-686; doi:10.2337/diacare.21.5.682
Leptinemia Is Not a Risk Factor for Ischemic Heart Disease in Men: Prospective results from the Quebec Cardiovascular Study
Diabetes Care May 1998 21:782-786; doi:10.2337/diacare.21.5.782
Adaptation of the Dartmouth COOP Charts for Use Among American Indian People With Diabetes Diabetes Care May 1998 21:770-776; doi:10.2337/diacare.21.5.770
Effect of Insulin Administration on Serum Lipoprotein(a) and Its Phenotypes in New-Onset IDDM Patients Diabetes Care May 1998 21:866-867; doi:10.2337/diacare.21.5.866
Chapuis, Anne-Sophie
Moderate Intake of n-3 Fatty Acids for 2 Months Has No Detrimental Effect on Glucose Metabolism and Could Ameliorate the Lipid
Profile in Type 2 Diabetic Men: Results of a controlled study Diabetes Care May 1998 21:717-724; doi:10.2337/diacare.21.5.717
Lispro Insulin Is Suitable for External Pumps but Not for Implantable Pumps Diabetes Care May 1998 21:867-868; doi:10.2337/diacare.21.5.867
Chevalier, Annie
Moderate Intake of n-3 Fatty Acids for 2 Months Has No Detrimental Effect on Glucose Metabolism and Could Ameliorate the Lipid
Profile in Type 2 Diabetic Men: Results of a controlled study Diabetes Care May 1998 21:717-724; doi:10.2337/diacare.21.5.717
The Determinants of Glycemic Responses to Diet Restriction and Weight Loss in Obesity and NIDDM Diabetes Care May 1998 21:687-694; doi:10.2337/diacare.21.5.687
Beneficial Effect on Average Lipid Levels From Energy Restriction and Fat Loss in Obese Individuals With or Without Type 2
Diabetes Diabetes Care May 1998 21:695-700; doi:10.2337/diacare.21.5.695
Evaluation of the Insertion/Deletion ACE Gene Polymorphism as a Risk Factor for Carotid Artery Intima-Media Thickening and
Hypertension in Young Type 1 Diabetic Patients Diabetes Care May 1998 21:836-840; doi:10.2337/diacare.21.5.836
Moderate Intake of n-3 Fatty Acids for 2 Months Has No Detrimental Effect on Glucose Metabolism and Could Ameliorate the Lipid
Profile in Type 2 Diabetic Men: Results of a controlled study Diabetes Care May 1998 21:717-724; doi:10.2337/diacare.21.5.717
Absence of Association Between Genetic Variation of the β3-Adrenercjic Receptor and Metabolic Pnenotypes in Oji-Cree Diabetes Care May 1998 21:851-854; doi:10.2337/diacare.21.5.851
Use of a Laser Skin Perforator for Determination of Capillary Blood Glucose Yields Reliable Results and High Patient Acceptability
Diabetes Care May 1998 21:871-873; doi:10.2337/diacare.21.5.871
Couillard, Charles
Leptinemia Is Not a Risk Factor for Ischemic Heart Disease in Men: Prospective results from the Quebec Cardiovascular Study
Diabetes Care May 1998 21:782-786; doi:10.2337/diacare.21.5.782
The Effect of Magnesium Supplementation in Increasing Doses on the Control of Type 2 Diabetes Diabetes Care May 1998 21:682-686; doi:10.2337/diacare.21.5.682
Leptinemia Is Not a Risk Factor for Ischemic Heart Disease in Men: Prospective results from the Quebec Cardiovascular Study
Diabetes Care May 1998 21:782-786; doi:10.2337/diacare.21.5.782
Adaptation of the Dartmouth COOP Charts for Use Among American Indian People With Diabetes Diabetes Care May 1998 21:770-776; doi:10.2337/diacare.21.5.770
Objective Assessment of Smoking Habits by Urinary Cotinine Measurement in Adolescents and Young Adults With Type 1 Diabetes:
Reliability of reported cigarette consumption and relationship to urinary albumin excretion Diabetes Care May 1998 21:787-791; doi:10.2337/diacare.21.5.787
The Effect of Magnesium Supplementation in Increasing Doses on the Control of Type 2 Diabetes Diabetes Care May 1998 21:682-686; doi:10.2337/diacare.21.5.682
Troglitazone Decreases the Proportion of Small, Dense LDL and Increases the Resistance of LDL to Oxidation in Obese Subjects
Diabetes Care May 1998 21:796-799; doi:10.2337/diacare.21.5.796
Leptinemia Is Not a Risk Factor for Ischemic Heart Disease in Men: Prospective results from the Quebec Cardiovascular Study
Diabetes Care May 1998 21:782-786; doi:10.2337/diacare.21.5.782
Moderate Intake of n-3 Fatty Acids for 2 Months Has No Detrimental Effect on Glucose Metabolism and Could Ameliorate the Lipid
Profile in Type 2 Diabetic Men: Results of a controlled study Diabetes Care May 1998 21:717-724; doi:10.2337/diacare.21.5.717
The Effects of Metformin on Glycemic Control and Serum Lipids in Insulin-Treated NIDDM Patients With Suboptimal Metabolic
Control Diabetes Care May 1998 21:701-705; doi:10.2337/diacare.21.5.701
Beneficial Effect on Average Lipid Levels From Energy Restriction and Fat Loss in Obese Individuals With or Without Type 2
Diabetes Diabetes Care May 1998 21:695-700; doi:10.2337/diacare.21.5.695
Use of a Laser Skin Perforator for Determination of Capillary Blood Glucose Yields Reliable Results and High Patient Acceptability
Diabetes Care May 1998 21:871-873; doi:10.2337/diacare.21.5.871
Frost, Dietmar
Evaluation of the Insertion/Deletion ACE Gene Polymorphism as a Risk Factor for Carotid Artery Intima-Media Thickening and
Hypertension in Young Type 1 Diabetic Patients Diabetes Care May 1998 21:836-840; doi:10.2337/diacare.21.5.836
Development and Application of a Model to Estimate the Impact of Type 1 Diabetes on Health-Related Quality of Life Diabetes Care May 1998 21:725-731; doi:10.2337/diacare.21.5.725
The Determinants of Glycemic Responses to Diet Restriction and Weight Loss in Obesity and NIDDM Diabetes Care May 1998 21:687-694; doi:10.2337/diacare.21.5.687
Do Postmenopausal Women With NIDDM Have a Reduced Capacity to Deposit and Conserve Lower-Body Fat? Diabetes Care May 1998 21:828-830; doi:10.2337/diacare.21.5.828
Adaptation of the Dartmouth COOP Charts for Use Among American Indian People With Diabetes Diabetes Care May 1998 21:770-776; doi:10.2337/diacare.21.5.770
Objective Assessment of Smoking Habits by Urinary Cotinine Measurement in Adolescents and Young Adults With Type 1 Diabetes:
Reliability of reported cigarette consumption and relationship to urinary albumin excretion Diabetes Care May 1998 21:787-791; doi:10.2337/diacare.21.5.787
Moderate Intake of n-3 Fatty Acids for 2 Months Has No Detrimental Effect on Glucose Metabolism and Could Ameliorate the Lipid
Profile in Type 2 Diabetic Men: Results of a controlled study Diabetes Care May 1998 21:717-724; doi:10.2337/diacare.21.5.717
Absence of Association Between Genetic Variation of the β3-Adrenercjic Receptor and Metabolic Pnenotypes in Oji-Cree Diabetes Care May 1998 21:851-854; doi:10.2337/diacare.21.5.851
Application of the Revised American Diabetes Association Criteria for the Diagnosis of Diabetes in a Canadian Native Population
Diabetes Care May 1998 21:870-871; doi:10.2337/diacare.21.5.870
Haring, Hans-Ulrich
Evaluation of the Insertion/Deletion ACE Gene Polymorphism as a Risk Factor for Carotid Artery Intima-Media Thickening and
Hypertension in Young Type 1 Diabetic Patients Diabetes Care May 1998 21:836-840; doi:10.2337/diacare.21.5.836
Validation of a Diabetic Wound Classification System: The contribution of depth, infection, and ischemia to risk of amputation
Diabetes Care May 1998 21:855-859; doi:10.2337/diacare.21.5.855
Absence of Association Between Genetic Variation of the β3-Adrenercjic Receptor and Metabolic Pnenotypes in Oji-Cree Diabetes Care May 1998 21:851-854; doi:10.2337/diacare.21.5.851
Application of the Revised American Diabetes Association Criteria for the Diagnosis of Diabetes in a Canadian Native Population
Diabetes Care May 1998 21:870-871; doi:10.2337/diacare.21.5.870
Hawk, Barbara
Incidence of IDDM in Children Living in Puerto Rico Diabetes Care May 1998 21:744-746; doi:10.2337/diacare.21.5.744
Enhanced Subclinical Coagulation Activation During Diabetic Ketoacidosis Diabetes Care May 1998 21:868-870; doi:10.2337/diacare.21.5.868
Hegele, Robert A
Absence of Association Between Genetic Variation of the β3-Adrenercjic Receptor and Metabolic Pnenotypes in Oji-Cree Diabetes Care May 1998 21:851-854; doi:10.2337/diacare.21.5.851
Variants of the Fatty Acid-Binding Protein 2 Gene Are Not Associated With Coronary Heart Disease in Nondiabetic Subjects and
in Patients With NIDDM Diabetes Care May 1998 21:849-850; doi:10.2337/diacare.21.5.849
Objective Assessment of Smoking Habits by Urinary Cotinine Measurement in Adolescents and Young Adults With Type 1 Diabetes:
Reliability of reported cigarette consumption and relationship to urinary albumin excretion Diabetes Care May 1998 21:787-791; doi:10.2337/diacare.21.5.787
Effect of Insulin Administration on Serum Lipoprotein(a) and Its Phenotypes in New-Onset IDDM Patients Diabetes Care May 1998 21:866-867; doi:10.2337/diacare.21.5.866
Hess, George E
The Reliability and Validity of a Brief Diabetes Knowledge Test Diabetes Care May 1998 21:706-710; doi:10.2337/diacare.21.5.706
Adaptation of the Dartmouth COOP Charts for Use Among American Indian People With Diabetes Diabetes Care May 1998 21:770-776; doi:10.2337/diacare.21.5.770
Comparison of Human Regular and Lispro Insulins After Interruption of Continuous Subcutaneous Insulin Infusion and in the
Treatment of Acutely Decompensated IDDM Diabetes Care May 1998 21:817-821; doi:10.2337/diacare.21.5.817
Objective Assessment of Smoking Habits by Urinary Cotinine Measurement in Adolescents and Young Adults With Type 1 Diabetes:
Reliability of reported cigarette consumption and relationship to urinary albumin excretion Diabetes Care May 1998 21:787-791; doi:10.2337/diacare.21.5.787
Changes in Amylin and Amylin-Like Peptide Concentrations ana (β-Cell Function in Response to Sulfonylurea or Insulin Therapy
in NIDDM Diabetes Care May 1998 21:810-816; doi:10.2337/diacare.21.5.810
Do Postmenopausal Women With NIDDM Have a Reduced Capacity to Deposit and Conserve Lower-Body Fat? Diabetes Care May 1998 21:828-830; doi:10.2337/diacare.21.5.828
Codon 972 Polymorphism of the Insulin Receptor Substrate-1 Gene in Impaired Glucose Tolerance and Late-Onset NIDDM Diabetes Care May 1998 21:753-756; doi:10.2337/diacare.21.5.753
Enhanced Subclinical Coagulation Activation During Diabetic Ketoacidosis Diabetes Care May 1998 21:868-870; doi:10.2337/diacare.21.5.868
J
Jenkins, Arthur B
The Determinants of Glycemic Responses to Diet Restriction and Weight Loss in Obesity and NIDDM Diabetes Care May 1998 21:687-694; doi:10.2337/diacare.21.5.687
Beneficial Effect on Average Lipid Levels From Energy Restriction and Fat Loss in Obese Individuals With or Without Type 2
Diabetes Diabetes Care May 1998 21:695-700; doi:10.2337/diacare.21.5.695
The Effects of Metformin on Glycemic Control and Serum Lipids in Insulin-Treated NIDDM Patients With Suboptimal Metabolic
Control Diabetes Care May 1998 21:701-705; doi:10.2337/diacare.21.5.701
Comparison of Human Regular and Lispro Insulins After Interruption of Continuous Subcutaneous Insulin Infusion and in the
Treatment of Acutely Decompensated IDDM Diabetes Care May 1998 21:817-821; doi:10.2337/diacare.21.5.817
Enhanced Subclinical Coagulation Activation During Diabetic Ketoacidosis Diabetes Care May 1998 21:868-870; doi:10.2337/diacare.21.5.868
Kareinen, Anu
Variants of the Fatty Acid-Binding Protein 2 Gene Are Not Associated With Coronary Heart Disease in Nondiabetic Subjects and
in Patients With NIDDM Diabetes Care May 1998 21:849-850; doi:10.2337/diacare.21.5.849
Beneficial Impact of Ramipril on Left Ventricular Hypertrophy in Normotensive Nonalbummuric NIDDM Patients Diabetes Care May 1998 21:804-809; doi:10.2337/diacare.21.5.804
Enhanced Subclinical Coagulation Activation During Diabetic Ketoacidosis Diabetes Care May 1998 21:868-870; doi:10.2337/diacare.21.5.868
Klein, Barbara EK
Development and Application of a Model to Estimate the Impact of Type 1 Diabetes on Health-Related Quality of Life Diabetes Care May 1998 21:725-731; doi:10.2337/diacare.21.5.725
Development and Application of a Model to Estimate the Impact of Type 1 Diabetes on Health-Related Quality of Life Diabetes Care May 1998 21:725-731; doi:10.2337/diacare.21.5.725
Development of Proliferative Diabetic Retinopathy in African-Americans and Whites With Type 1 Diabetes Diabetes Care May 1998 21:792-795; doi:10.2337/diacare.21.5.792
Codon 972 Polymorphism of the Insulin Receptor Substrate-1 Gene in Impaired Glucose Tolerance and Late-Onset NIDDM Diabetes Care May 1998 21:753-756; doi:10.2337/diacare.21.5.753
Codon 972 Polymorphism of the Insulin Receptor Substrate-1 Gene in Impaired Glucose Tolerance and Late-Onset NIDDM Diabetes Care May 1998 21:753-756; doi:10.2337/diacare.21.5.753
Codon 972 Polymorphism of the Insulin Receptor Substrate-1 Gene in Impaired Glucose Tolerance and Late-Onset NIDDM Diabetes Care May 1998 21:753-756; doi:10.2337/diacare.21.5.753
Codon 972 Polymorphism of the Insulin Receptor Substrate-1 Gene in Impaired Glucose Tolerance and Late-Onset NIDDM Diabetes Care May 1998 21:753-756; doi:10.2337/diacare.21.5.753
The Determinants of Glycemic Responses to Diet Restriction and Weight Loss in Obesity and NIDDM Diabetes Care May 1998 21:687-694; doi:10.2337/diacare.21.5.687
Patterns of Expenditures and Use of Services Among Older Adults With Diabetes: Implications for the transition to capitated
managed care Diabetes Care May 1998 21:747-752; doi:10.2337/diacare.21.5.747
Variants of the Fatty Acid-Binding Protein 2 Gene Are Not Associated With Coronary Heart Disease in Nondiabetic Subjects and
in Patients With NIDDM Diabetes Care May 1998 21:849-850; doi:10.2337/diacare.21.5.849
Leptinemia Is Not a Risk Factor for Ischemic Heart Disease in Men: Prospective results from the Quebec Cardiovascular Study
Diabetes Care May 1998 21:782-786; doi:10.2337/diacare.21.5.782
Validation of a Diabetic Wound Classification System: The contribution of depth, infection, and ischemia to risk of amputation
Diabetes Care May 1998 21:855-859; doi:10.2337/diacare.21.5.855
Variants of the Fatty Acid-Binding Protein 2 Gene Are Not Associated With Coronary Heart Disease in Nondiabetic Subjects and
in Patients With NIDDM Diabetes Care May 1998 21:849-850; doi:10.2337/diacare.21.5.849
Changes in Amylin and Amylin-Like Peptide Concentrations ana (β-Cell Function in Response to Sulfonylurea or Insulin Therapy
in NIDDM Diabetes Care May 1998 21:810-816; doi:10.2337/diacare.21.5.810
Use of the Therapeutic Footwear Benefit Among Diabetic Medicare Beneficiaries in Three States, 1995 Diabetes Care May 1998 21:777-781; doi:10.2337/diacare.21.5.777
Moderate Intake of n-3 Fatty Acids for 2 Months Has No Detrimental Effect on Glucose Metabolism and Could Ameliorate the Lipid
Profile in Type 2 Diabetic Men: Results of a controlled study Diabetes Care May 1998 21:717-724; doi:10.2337/diacare.21.5.717
Leptinemia Is Not a Risk Factor for Ischemic Heart Disease in Men: Prospective results from the Quebec Cardiovascular Study
Diabetes Care May 1998 21:782-786; doi:10.2337/diacare.21.5.782
The Determinants of Glycemic Responses to Diet Restriction and Weight Loss in Obesity and NIDDM Diabetes Care May 1998 21:687-694; doi:10.2337/diacare.21.5.687
Beneficial Effect on Average Lipid Levels From Energy Restriction and Fat Loss in Obese Individuals With or Without Type 2
Diabetes Diabetes Care May 1998 21:695-700; doi:10.2337/diacare.21.5.695
Effect of Insulin Administration on Serum Lipoprotein(a) and Its Phenotypes in New-Onset IDDM Patients Diabetes Care May 1998 21:866-867; doi:10.2337/diacare.21.5.866
Mauriège, Pascale
Leptinemia Is Not a Risk Factor for Ischemic Heart Disease in Men: Prospective results from the Quebec Cardiovascular Study
Diabetes Care May 1998 21:782-786; doi:10.2337/diacare.21.5.782
Adaptation of the Dartmouth COOP Charts for Use Among American Indian People With Diabetes Diabetes Care May 1998 21:770-776; doi:10.2337/diacare.21.5.770
Effect of Meal Dilution on the Postprandial Glycemic Response: Implications for glycemic testing Diabetes Care May 1998 21:711-716; doi:10.2337/diacare.21.5.711
Effect of Insulin Administration on Serum Lipoprotein(a) and Its Phenotypes in New-Onset IDDM Patients Diabetes Care May 1998 21:866-867; doi:10.2337/diacare.21.5.866
Moorjani, Sital
Leptinemia Is Not a Risk Factor for Ischemic Heart Disease in Men: Prospective results from the Quebec Cardiovascular Study
Diabetes Care May 1998 21:782-786; doi:10.2337/diacare.21.5.782
Enhanced Subclinical Coagulation Activation During Diabetic Ketoacidosis Diabetes Care May 1998 21:868-870; doi:10.2337/diacare.21.5.868
Mühlhauser, Ingrid
Validation of a Diabetes-Specific Quality-of-Life Scale for Patients With Type 1 Diabetes Diabetes Care May 1998 21:757-769; doi:10.2337/diacare.21.5.757
Beneficial Impact of Ramipril on Left Ventricular Hypertrophy in Normotensive Nonalbummuric NIDDM Patients Diabetes Care May 1998 21:804-809; doi:10.2337/diacare.21.5.804
Codon 972 Polymorphism of the Insulin Receptor Substrate-1 Gene in Impaired Glucose Tolerance and Late-Onset NIDDM Diabetes Care May 1998 21:753-756; doi:10.2337/diacare.21.5.753
Do Postmenopausal Women With NIDDM Have a Reduced Capacity to Deposit and Conserve Lower-Body Fat? Diabetes Care May 1998 21:828-830; doi:10.2337/diacare.21.5.828
Moderate Intake of n-3 Fatty Acids for 2 Months Has No Detrimental Effect on Glucose Metabolism and Could Ameliorate the Lipid
Profile in Type 2 Diabetic Men: Results of a controlled study Diabetes Care May 1998 21:717-724; doi:10.2337/diacare.21.5.717
Validation of a Diabetes-Specific Quality-of-Life Scale for Patients With Type 1 Diabetes Diabetes Care May 1998 21:757-769; doi:10.2337/diacare.21.5.757
Adaptation of the Dartmouth COOP Charts for Use Among American Indian People With Diabetes Diabetes Care May 1998 21:770-776; doi:10.2337/diacare.21.5.770
Beneficial Impact of Ramipril on Left Ventricular Hypertrophy in Normotensive Nonalbummuric NIDDM Patients Diabetes Care May 1998 21:804-809; doi:10.2337/diacare.21.5.804
Changes in Amylin and Amylin-Like Peptide Concentrations ana (β-Cell Function in Response to Sulfonylurea or Insulin Therapy
in NIDDM Diabetes Care May 1998 21:810-816; doi:10.2337/diacare.21.5.810
Use of a Laser Skin Perforator for Determination of Capillary Blood Glucose Yields Reliable Results and High Patient Acceptability
Diabetes Care May 1998 21:871-873; doi:10.2337/diacare.21.5.871
Perez, Georgia E
Adaptation of the Dartmouth COOP Charts for Use Among American Indian People With Diabetes Diabetes Care May 1998 21:770-776; doi:10.2337/diacare.21.5.770
Evaluation of the Insertion/Deletion ACE Gene Polymorphism as a Risk Factor for Carotid Artery Intima-Media Thickening and
Hypertension in Young Type 1 Diabetic Patients Diabetes Care May 1998 21:836-840; doi:10.2337/diacare.21.5.836
The Effect of Magnesium Supplementation in Increasing Doses on the Control of Type 2 Diabetes Diabetes Care May 1998 21:682-686; doi:10.2337/diacare.21.5.682
Patterns of Expenditures and Use of Services Among Older Adults With Diabetes: Implications for the transition to capitated
managed care Diabetes Care May 1998 21:747-752; doi:10.2337/diacare.21.5.747
Use of the Therapeutic Footwear Benefit Among Diabetic Medicare Beneficiaries in Three States, 1995 Diabetes Care May 1998 21:777-781; doi:10.2337/diacare.21.5.777
Variants of the Fatty Acid-Binding Protein 2 Gene Are Not Associated With Coronary Heart Disease in Nondiabetic Subjects and
in Patients With NIDDM Diabetes Care May 1998 21:849-850; doi:10.2337/diacare.21.5.849
Changes in Amylin and Amylin-Like Peptide Concentrations ana (β-Cell Function in Response to Sulfonylurea or Insulin Therapy
in NIDDM Diabetes Care May 1998 21:810-816; doi:10.2337/diacare.21.5.810
Use of the Therapeutic Footwear Benefit Among Diabetic Medicare Beneficiaries in Three States, 1995 Diabetes Care May 1998 21:777-781; doi:10.2337/diacare.21.5.777
Development of Proliferative Diabetic Retinopathy in African-Americans and Whites With Type 1 Diabetes Diabetes Care May 1998 21:792-795; doi:10.2337/diacare.21.5.792
Moderate Intake of n-3 Fatty Acids for 2 Months Has No Detrimental Effect on Glucose Metabolism and Could Ameliorate the Lipid
Profile in Type 2 Diabetic Men: Results of a controlled study Diabetes Care May 1998 21:717-724; doi:10.2337/diacare.21.5.717
The Effects of Metformin on Glycemic Control and Serum Lipids in Insulin-Treated NIDDM Patients With Suboptimal Metabolic
Control Diabetes Care May 1998 21:701-705; doi:10.2337/diacare.21.5.701
The Effects of Metformin on Glycemic Control and Serum Lipids in Insulin-Treated NIDDM Patients With Suboptimal Metabolic
Control Diabetes Care May 1998 21:701-705; doi:10.2337/diacare.21.5.701
The Effect of Magnesium Supplementation in Increasing Doses on the Control of Type 2 Diabetes Diabetes Care May 1998 21:682-686; doi:10.2337/diacare.21.5.682
Variants of the Fatty Acid-Binding Protein 2 Gene Are Not Associated With Coronary Heart Disease in Nondiabetic Subjects and
in Patients With NIDDM Diabetes Care May 1998 21:849-850; doi:10.2337/diacare.21.5.849
Development and Application of a Model to Estimate the Impact of Type 1 Diabetes on Health-Related Quality of Life Diabetes Care May 1998 21:725-731; doi:10.2337/diacare.21.5.725
Development of Proliferative Diabetic Retinopathy in African-Americans and Whites With Type 1 Diabetes Diabetes Care May 1998 21:792-795; doi:10.2337/diacare.21.5.792
Beneficial Impact of Ramipril on Left Ventricular Hypertrophy in Normotensive Nonalbummuric NIDDM Patients Diabetes Care May 1998 21:804-809; doi:10.2337/diacare.21.5.804
Patterns of Expenditures and Use of Services Among Older Adults With Diabetes: Implications for the transition to capitated
managed care Diabetes Care May 1998 21:747-752; doi:10.2337/diacare.21.5.747
Patterns of Expenditures and Use of Services Among Older Adults With Diabetes: Implications for the transition to capitated
managed care Diabetes Care May 1998 21:747-752; doi:10.2337/diacare.21.5.747
Codon 972 Polymorphism of the Insulin Receptor Substrate-1 Gene in Impaired Glucose Tolerance and Late-Onset NIDDM Diabetes Care May 1998 21:753-756; doi:10.2337/diacare.21.5.753
Effect of Meal Dilution on the Postprandial Glycemic Response: Implications for glycemic testing Diabetes Care May 1998 21:711-716; doi:10.2337/diacare.21.5.711
Beneficial Effect on Average Lipid Levels From Energy Restriction and Fat Loss in Obese Individuals With or Without Type 2
Diabetes Diabetes Care May 1998 21:695-700; doi:10.2337/diacare.21.5.695
Effect of Insulin Administration on Serum Lipoprotein(a) and Its Phenotypes in New-Onset IDDM Patients Diabetes Care May 1998 21:866-867; doi:10.2337/diacare.21.5.866
Slama, Gerard
Lispro Insulin Is Suitable for External Pumps but Not for Implantable Pumps Diabetes Care May 1998 21:867-868; doi:10.2337/diacare.21.5.867
Slama, Gérard
Moderate Intake of n-3 Fatty Acids for 2 Months Has No Detrimental Effect on Glucose Metabolism and Could Ameliorate the Lipid
Profile in Type 2 Diabetic Men: Results of a controlled study Diabetes Care May 1998 21:717-724; doi:10.2337/diacare.21.5.717
Beneficial Impact of Ramipril on Left Ventricular Hypertrophy in Normotensive Nonalbummuric NIDDM Patients Diabetes Care May 1998 21:804-809; doi:10.2337/diacare.21.5.804
Efficacy and Safely of a Topical Gel Formulation of Recombinant Human Platelet-Derived Growth Factor-BB (Becaplermin) in Patients
With Chronic Neuropathic Diabetic Ulcers: A phase III randomized placebo-controlled double-blind study Diabetes Care May 1998 21:822-827; doi:10.2337/diacare.21.5.822
Troglitazone Decreases the Proportion of Small, Dense LDL and Increases the Resistance of LDL to Oxidation in Obese Subjects
Diabetes Care May 1998 21:796-799; doi:10.2337/diacare.21.5.796
Troglitazone Decreases the Proportion of Small, Dense LDL and Increases the Resistance of LDL to Oxidation in Obese Subjects
Diabetes Care May 1998 21:796-799; doi:10.2337/diacare.21.5.796
Do Postmenopausal Women With NIDDM Have a Reduced Capacity to Deposit and Conserve Lower-Body Fat? Diabetes Care May 1998 21:828-830; doi:10.2337/diacare.21.5.828
Use of the Therapeutic Footwear Benefit Among Diabetic Medicare Beneficiaries in Three States, 1995 Diabetes Care May 1998 21:777-781; doi:10.2337/diacare.21.5.777
Efficacy and Safely of a Topical Gel Formulation of Recombinant Human Platelet-Derived Growth Factor-BB (Becaplermin) in Patients
With Chronic Neuropathic Diabetic Ulcers: A phase III randomized placebo-controlled double-blind study Diabetes Care May 1998 21:822-827; doi:10.2337/diacare.21.5.822
Troglitazone Decreases the Proportion of Small, Dense LDL and Increases the Resistance of LDL to Oxidation in Obese Subjects
Diabetes Care May 1998 21:796-799; doi:10.2337/diacare.21.5.796
Comparison of Human Regular and Lispro Insulins After Interruption of Continuous Subcutaneous Insulin Infusion and in the
Treatment of Acutely Decompensated IDDM Diabetes Care May 1998 21:817-821; doi:10.2337/diacare.21.5.817
Glucose Intolerance in Pregnant Women and Its Effects on Newborn Outcomes Diabetes Care May 1998 21:873-874; doi:10.2337/diacare.21.5.873
Tarnow, Lise
Beneficial Impact of Ramipril on Left Ventricular Hypertrophy in Normotensive Nonalbummuric NIDDM Patients Diabetes Care May 1998 21:804-809; doi:10.2337/diacare.21.5.804
Development and Application of a Model to Estimate the Impact of Type 1 Diabetes on Health-Related Quality of Life Diabetes Care May 1998 21:725-731; doi:10.2337/diacare.21.5.725
Development and Application of a Model to Estimate the Impact of Type 1 Diabetes on Health-Related Quality of Life Diabetes Care May 1998 21:725-731; doi:10.2337/diacare.21.5.725
Changes in Amylin and Amylin-Like Peptide Concentrations ana (β-Cell Function in Response to Sulfonylurea or Insulin Therapy
in NIDDM Diabetes Care May 1998 21:810-816; doi:10.2337/diacare.21.5.810
Glucose Intolerance in Pregnant Women and Its Effects on Newborn Outcomes Diabetes Care May 1998 21:873-874; doi:10.2337/diacare.21.5.873
Vidal, Hubert
Moderate Intake of n-3 Fatty Acids for 2 Months Has No Detrimental Effect on Glucose Metabolism and Could Ameliorate the Lipid
Profile in Type 2 Diabetic Men: Results of a controlled study Diabetes Care May 1998 21:717-724; doi:10.2337/diacare.21.5.717
Effect of Meal Dilution on the Postprandial Glycemic Response: Implications for glycemic testing Diabetes Care May 1998 21:711-716; doi:10.2337/diacare.21.5.711
Do Postmenopausal Women With NIDDM Have a Reduced Capacity to Deposit and Conserve Lower-Body Fat? Diabetes Care May 1998 21:828-830; doi:10.2337/diacare.21.5.828
Patterns of Expenditures and Use of Services Among Older Adults With Diabetes: Implications for the transition to capitated
managed care Diabetes Care May 1998 21:747-752; doi:10.2337/diacare.21.5.747
Efficacy and Safely of a Topical Gel Formulation of Recombinant Human Platelet-Derived Growth Factor-BB (Becaplermin) in Patients
With Chronic Neuropathic Diabetic Ulcers: A phase III randomized placebo-controlled double-blind study Diabetes Care May 1998 21:822-827; doi:10.2337/diacare.21.5.822
Adaptation of the Dartmouth COOP Charts for Use Among American Indian People With Diabetes Diabetes Care May 1998 21:770-776; doi:10.2337/diacare.21.5.770
Effect of Meal Dilution on the Postprandial Glycemic Response: Implications for glycemic testing Diabetes Care May 1998 21:711-716; doi:10.2337/diacare.21.5.711
Development and Application of a Model to Estimate the Impact of Type 1 Diabetes on Health-Related Quality of Life Diabetes Care May 1998 21:725-731; doi:10.2337/diacare.21.5.725
Codon 972 Polymorphism of the Insulin Receptor Substrate-1 Gene in Impaired Glucose Tolerance and Late-Onset NIDDM Diabetes Care May 1998 21:753-756; doi:10.2337/diacare.21.5.753
Codon 972 Polymorphism of the Insulin Receptor Substrate-1 Gene in Impaired Glucose Tolerance and Late-Onset NIDDM Diabetes Care May 1998 21:753-756; doi:10.2337/diacare.21.5.753
Absence of Association Between Genetic Variation of the β3-Adrenercjic Receptor and Metabolic Pnenotypes in Oji-Cree Diabetes Care May 1998 21:851-854; doi:10.2337/diacare.21.5.851
Application of the Revised American Diabetes Association Criteria for the Diagnosis of Diabetes in a Canadian Native Population
Diabetes Care May 1998 21:870-871; doi:10.2337/diacare.21.5.870
Zirinis, Phédon
Lispro Insulin Is Suitable for External Pumps but Not for Implantable Pumps Diabetes Care May 1998 21:867-868; doi:10.2337/diacare.21.5.867
Zumbach, Martina S
Hyperhomocyst(e)inemia and Endothelial Dysfunction in IDDM Diabetes Care May 1998 21:841-848; doi:10.2337/diacare.21.5.841